SS
IMUX icon

Steve Schonfeld’s Immunic IMUX Stock Holding History

Steve Schonfeld’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,830
Closed -$31.4K – 2791
2026
Q1 		$31.4K Buy
+2,830
New +$25.3K ﹤0.01% 2019
2025
Q2 		– Sell
-4,577
Closed -$49.9K – 2259
2025
Q1 		$49.9K Buy
+4,577
New +$49.4K ﹤0.01% 2072
2024
Q4 		– Sell
-1,660
Closed -$27.4K – 2188
2024
Q3 		$27.4K Sell
1,660
-1,160
-41% -$16.5K ﹤0.01% 1913
2024
Q2 		$31.3K Sell
2,820
-2,480
-47% -$30.8K ﹤0.01% 1978
2024
Q1 		$70K Sell
5,300
-7,670
-59% -$99.7K ﹤0.01% 1879
2023
Q4 		$195K Sell
12,970
-10,900
-46% -$134K ﹤0.01% 1538
2023
Q3 		$351K Buy
23,870
+6,380
+36% +$123K ﹤0.01% 1296
2023
Q2 		$439K Buy
17,490
+4,190
+32% +$70.2K ﹤0.01% 1268
2023
Q1 		$198K Buy
+13,300
New +$247K ﹤0.01% 1547
2022
Q4 		– Sell
-10,440
Closed -$330K – 2794
2022
Q3 		$330K Buy
10,440
+270
+3% +$11.3K ﹤0.01% 2020
2022
Q2 		$353K Buy
10,170
+2,070
+26% +$133K ﹤0.01% 1563
2022
Q1 		$916K Buy
8,100
+2,470
+44% +$286K 0.01% 1037
2021
Q4 		$539K Buy
5,630
+190
+3% +$17.1K ﹤0.01% 1222
2021
Q3 		$482K Buy
5,440
+350
+7% +$34.4K 0.01% 1294
2021
Q2 		$624K Buy
5,090
+880
+21% +$122K 0.01% 1089
2021
Q1 		$671K Buy
4,210
+250
+6% +$42.4K 0.01% 1041
2020
Q4 		$605K Sell
3,960
-5,180
-57% -$930K 0.01% 982
2020
Q3 		$1.7M Buy
9,140
+5,550
+155% +$909K 0.03% 554
2020
Q2 		$435K Buy
+3,590
New +$365K 0.01% 860

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Steve Schonfeld's IMUX Position: Q2 2026 in Review

Steve Schonfeld sold out of Immunic (IMUX) in Q2 2026, closing a stake of 2,830 shares — an estimated $31.4K sold.

Steve Schonfeld first reported a position in IMUX in Q2 2020 and held it in 19 quarters. The position peaked at $1.7M in Q3 2020. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Steve Schonfeld reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 2,830 Immunic shares in Q2 2026, an estimated $31.4K.
  • Steve Schonfeld first reported a position in Immunic in Q2 2020 and held it in 19 quarters.
  • Steve Schonfeld's Immunic position peaked at $1.7M in Q3 2020.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.